Type 1 DiabetesSUMMIT1NCT05671679
Supporting Meal Management in Type 1 Diabetes
A study testing SNAQ app and Traditional carbohydrate counting in people with Type 1 Diabetes, run by Lia Bally at 1 site in Switzerland.
Trial summary
Carbohydrate count marks the cornerstone of Type 1 Diabetes management. Eventhough it is a crucial task, it is burdensome and prone to error. Therefore, the investigators want to explore the effect that SNAQ, a food analyser app would have in glycaemic control by facilitating the task of carbohydrate estimation. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Type 1 Diabetes
- What is being tested?
- SNAQ app and Traditional carbohydrate counting
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 44 participants
- Where
- 1 siteSwitzerland
- Study dates
- 27 Mar 2023to 8 May 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Written informed consent
- Adults (aged 18 years or older)
- Type 1 diabetes (as defined by World Health Organization (WHO) for at least 12 month)
- Current use of a commercial hybrid closed-loop system
- HbA1c≤12% (measured within the past 3 months)
- Willing to use the SNAQ app on a daily basis for over 3 weeks
- The participant is willing to follow study specific instructions and share their treatment data with the study team
Who cannot join
- Any physical or psychological disease or condition likely to interfere with the normal conduct of the study and interpretation of the study results
- Previous use of SNAQ app for more than 5 days within the past 3 months
- Self-reported pregnancy, planed pregnancy within next 3 months or breast-feeding
- Severe visual impairment
- Severe hearing impairment
- Lack of reliable telephone facility for contact
- Concomitant participation in another trial that interferes with the normal conduct of the study and interpretation of the study results
- Participant not proficient in German
Trial locations and contacts
1 site in 1 country.
Switzerland1 site
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital
Bern, Canton of Bern, 3010
About this study
Carbohydrate count marks the cornerstone of Type 1 Diabetes management. Eventhough it is a crucial task, it is burdensome and prone to error. Therefore, the investigators want to explore the effect that SNAQ, a food analyser app would have in glycaemic control by facilitating the task of carbohydrate estimation.
Read the detailed description
Diet and physical activity are critically important in the lifestyle of people with type 1 diabetes. When diagnosed with the disease, people with type 1 diabetes are educated about nutritional goals and how to estimate nutritional content of food. Carbohydrates are the food component with the greatest impact on blood glucose levels and typical sources in the diet include starches, some vegetables, fruits, dairy products and sugars . Thus, people with type 1 diabetes are primarily being trained to estimate the carbohydrate content of food, a task that is also referred to as carbohydrate counting. Different methods can be used to count carbohydrate in food and drink. These include reading the nutritional labels, consulting reference books or websites, carrying a database on a personal digital assistant or using exchange tables which provides the carbohydrate content for typical serving sizes (e.g. 1 slice of bread). While nutritional information can be accessed through the above mentioned methods, the quantification of the portion sizes (if not indicated on the food package) requires the additional use of scale or measuring vessel. Given the required effort and time investment related to these methods, the great majority of people with type 1 diabetes count carbohydrates by visual estimation and experience. As a consequence, people's estimate often deviate substantially from ground truth values and average carbohydrate estimation errors reported in the literature are 20% or higher.
Of note, more than 60% of individuals with diabetes report having trouble with carbohydrate counting, despite their awareness on its importance . Even in patients who are confident in applying carbohydrate counting, the daily task is perceived as major burden of diabetes self-management.
Since carbohydrate counting is particularly demanding when eating fresh, non-packaged foods, a concerning trend towards unhealthy dietary choices with preference of prepackaged foods (with accessible nutrition facts) over whole foods is increasingly observed in people with type 1 diabetes. This is paralleled by an increasing prevalence of overweight and obesity in the type 1 diabetes population.
Thus, even with the latest hybrid closed-loop insulin delivery technologies, adequate nutrition knowledge remains a cornerstone for satisfactory glucose control, metabolic health, and prevention of diabetes-related complications and comorbidities.
With the development of new technologies embedded in modern smartphones (i.e. depth sensors), image-based methods to support food assessment have become widely available. Of particular use is the employment of well-established computer vision methodologies to estimate the quantity of food. When combined with food-recognition technologies and information from nutritional databases, a proposition of the nutritional content (e.g. carbohydrates, fat, proteins, fibres) can be made to the user on the basis of captured images and obviates the need for error prone visual estimations and mental calculations. Several such applications have become available and can support monitoring the diet as part of lifestyle management.
Insights from a recent online survey suggest that a high proportion of people with type 1 diabetes believe that such new technologies for meal management could facilitate their daily self-management and would be interested in using such technology. Moreover, according to a recent study, such digital tools may promote diabetes education and food literacy which may particularly benefit those with a lower education level and with a history of depression.
Amongst several options (e.g. Foodvisor, Calorie-Mamma, Lifesum) for image-based food tracking and analysis, SNAQ is one of the most commonly used app in people with type 1 diabetes. Up to date, more than 40000 users have downloaded the SNAQ app in their phones, of which 2,500 are living in Switzerland.
The investigators have previously demonstrated that the system estimates the macronutrient content of real meals with satisfying accuracy.
However, evidence with regards to the effect of the food analysis on daily self-management of people with type 1 diabetes (e.g. glucose control, meal patterns, perceived benefits) is currently lacking. The investigators therefore aim to address these aspects in a randomized-controlled study contrasting the use of the SNAQ app with people's traditional meal management techniques.
- Conditions
- Type 1 Diabetes
- Being tested
- SNAQ app, Traditional carbohydrate counting
- Keywords
- Carbohydrates, Continuous glucose measurement, Closed-loop systems, Type 1 Diabetes, Hyperglycaemia, Hypoglycaemia
- Medical subject headings
- Diabetes Mellitus, Type 1, Hyperglycemia, Hypoglycemia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SNAQ appOther
SNAQ is a smartphone food analysis app that estimates the macronutrient content of a meal, based on a single image. The app first determines meal content in terms of food components with input from the user to correct or add further components (e.g. foods, ingredients, sauces, herbs or seasonings). Then, the total macronutrient and energy content of the meal is determined based on the estimated volume and information from a nutritional database. Of note, the application also allows for assessing nutritional content of packaged foods by means of a barcode scanning function. The user can always adapt proposed nutritional contents at their own discretion. Meal macronutrients alongside the food pictures are collected in a detailed log which allows users to review their dietary choices. The product is not conceived by its manufacturer to be used for medical purposes and can thus not be considered a medical device.
Traditional carbohydrate countingOther
Patients will follow their traditional methods of carbohydrate counting during the control period. In addition to assess sustainability of the intervention, following the control period, the control group will also go an intervention period of 3 weeks using the SNAQ App.
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | The intervention group will use SNAQ app for the first 3 weeks (baseline to V1) of the study. Receives: Other: SNAQ app |
| Control | Active comparator | The control group will continue estimating the carbohydrate count using their traditional methods for the first three weeks of the study (baseline to V1). Receives: Other: Traditional carbohydrate counting |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of time with sensor glucose in the target range
Percentage of time with sensor glucose in the target range between 3.9 to 10.0mmol/L, %
Measured: 3-week intervention period (Day 1 to Day 21)
Secondary outcomes (11)
Percentage of time with sensor glucose in hyperglycaemia
Percentage of time with sensor glucose in the target range above 10.0mmol/L, %
Measured: 3-week intervention period (Day 1 to Day 21)
Percentage of time with sensor glucose in hypoglycaemia
Percentage of time with sensor glucose in the target range below 3.9 mmol/L, %
Measured: 3-week intervention period (Day 1 to Day 21)
Percentage of postprandial time with sensor glucose in target range
Percentage of postprandial time with sensor glucose in target range between 3.9 to 10.0 mmol/L
Measured: 3-week intervention period (Day 1 to Day 21)
Percentage of postprandial time with sensor glucose in hyperglycaemia
Percentage of postprandial time with sensor glucose in the target range above 10.0mmol/L, %
Measured: 3-week intervention period (Day 1 to Day 21)
Percentage of postprandial time with sensor glucose in hypoglycaemia
Percentage of postprandial time with sensor glucose in the target range below 3.9 mmol/L, %
Measured: 3-week intervention period (Day 1 to Day 21)
Sustainability: Change in percentage of time with sensor glucose in the target range
Sustainability: Change in the percentage of time with sensor glucose in target range (3.9 to 10.0mmol/L, %)
Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Sustainability: Change in the percentage of time with sensor glucose in hyperglycaemia
Sustainability: Change in percentage of time with sensor glucose above target range (>10.0mmol/L, %)
Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Sustainability: Change in the percentage of time with sensor glucose in hypoglycaemia
Sustainability: Change in percentage of time with sensor glucose below target range (<3.9mmol/L, %)
Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Sustainability: Change in the percentage of time with postprandial sensor glucose in target range
Sustainability: Change in the percentage of time with postprandial sensor glucose in target range (3.9 to 10.0mmol/L, %)
Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Sustainability: Change in the percentage of time with postprandial sensor glucose in hyperglycaemia
Sustainability: Change in the percentage of time with postprandial sensor glucose above target range (>10.0mmol/L, %)
Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Sustainability: Change in the percentage of postprandial time with sensor glucose in hypoglycaemia
Sustainability: Change in the percentage of postprandial time with sensor glucose below target range (<3.9mmol/L, %)
Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jan 2023
- Study start27 Mar 2023
- Primary completion8 May 2024
- Study completion8 May 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Type 1 DiabetesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The study will follow a randomized two-arm parallel design. Study visits will be done remotely via video calls or in-clinic when coinciding with usual care appointments. Following a baseline visit and before randomization, baseline characteristics and medical history of the participants will be collected (as detailed in section 4.3). Following randomization, the intervention group will use SNAQ app for the first 3 weeks while the control group will proceed without any modification/intervention by the study team. After the first 3 weeks, the control group will undergo 3 weeks of SNAQ app use (weeks 4-6). At the end of their respective SNAQ app periods (weeks 4-6 for the intervention group and weeks 7-9 for the control group), both groups will discontinue the use of SNAQ app for 3 weeks to assess sustainability of potential effects. Finally, both groups will be offered to use SNAQ app for 3 additional weeks as per their preference (follow-up period).
- Masking
- None (open label)
- Enrolment
- 44 participants (actual)
Sponsor and investigators
- Lead sponsor
- Lia Bally
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Lia Bally, Insel Gruppe AG, University Hospital Bern
- Investigators
- Lia Bally, MD PhD, Principal investigator, UDEM Inselspital, University Hospital of Berne, and University Berne
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05671679
- Sponsor's protocol ID
- SUMMIT1
- Acronym
- SUMMIT1
- Status last verified
- Jun 2024
- First submitted
- 22 Dec 2022
- Last updated
- 11 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Anonymised individual participant data will be shared after inquiry via a validated sharing platform (yet to be defined). Anonymised data packages will be available once the final study results are published in a peer-reviewed journal.
Study at a glance
From the registry record, last updated by the sponsor on 11 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Supporting Meal Management in Type 1 Diabetes
- ClinicalTrials.gov ID
- NCT05671679
- Acronym / sponsor ID
- SUMMIT1 / SUMMIT1
- Conditions
- Type 1 Diabetes
- Keywords
- Carbohydrates, Continuous glucose measurement, Closed-loop systems, Type 1 Diabetes, Hyperglycaemia, Hypoglycaemia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 44 participants (actual)
- Lead sponsor
- Lia BallyUniversity, hospital or other
- Study start
- 27 Mar 2023 (actual)
- Primary completion
- 8 May 2024 (actual)
- Study completion
- 8 May 2024 (actual)
- First posted
- 5 Jan 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Carbohydrate count marks the cornerstone of Type 1 Diabetes management. Eventhough it is a crucial task, it is burdensome and prone to error. Therefore, the investigators want to explore the effect that SNAQ, a food analyser app would have in glycaemic control by facilitating the task of carbohydrate estimation.
Detailed description
Diet and physical activity are critically important in the lifestyle of people with type 1 diabetes. When diagnosed with the disease, people with type 1 diabetes are educated about nutritional goals and how to estimate nutritional content of food. Carbohydrates are the food component with the greatest impact on blood glucose levels and typical sources in the diet include starches, some vegetables, fruits, dairy products and sugars . Thus, people with type 1 diabetes are primarily being trained to estimate the carbohydrate content of food, a task that is also referred to as carbohydrate counting. Different methods can be used to count carbohydrate in food and drink. These include reading the nutritional labels, consulting reference books or websites, carrying a database on a personal digital assistant or using exchange tables which provides the carbohydrate content for typical serving sizes (e.g. 1 slice of bread). While nutritional information can be accessed through the above mentioned methods, the quantification of the portion sizes (if not indicated on the food package) requires the additional use of scale or measuring vessel. Given the required effort and time investment related to these methods, the great majority of people with type 1 diabetes count carbohydrates by visual estimation and experience. As a consequence, people's estimate often deviate substantially from ground truth values and average carbohydrate estimation errors reported in the literature are 20% or higher.
Of note, more than 60% of individuals with diabetes report having trouble with carbohydrate counting, despite their awareness on its importance . Even in patients who are confident in applying carbohydrate counting, the daily task is perceived as major burden of diabetes self-management.
Since carbohydrate counting is particularly demanding when eating fresh, non-packaged foods, a concerning trend towards unhealthy dietary choices with preference of prepackaged foods (with accessible nutrition facts) over whole foods is increasingly observed in people with type 1 diabetes. This is paralleled by an increasing prevalence of overweight and obesity in the type 1 diabetes population.
Thus, even with the latest hybrid closed-loop insulin delivery technologies, adequate nutrition knowledge remains a cornerstone for satisfactory glucose control, metabolic health, and prevention of diabetes-related complications and comorbidities.
With the development of new technologies embedded in modern smartphones (i.e. depth sensors), image-based methods to support food assessment have become widely available. Of particular use is the employment of well-established computer vision methodologies to estimate the quantity of food. When combined with food-recognition technologies and information from nutritional databases, a proposition of the nutritional content (e.g. carbohydrates, fat, proteins, fibres) can be made to the user on the basis of captured images and obviates the need for error prone visual estimations and mental calculations. Several such applications have become available and can support monitoring the diet as part of lifestyle management.
Insights from a recent online survey suggest that a high proportion of people with type 1 diabetes believe that such new technologies for meal management could facilitate their daily self-management and would be interested in using such technology. Moreover, according to a recent study, such digital tools may promote diabetes education and food literacy which may particularly benefit those with a lower education level and with a history of depression.
Amongst several options (e.g. Foodvisor, Calorie-Mamma, Lifesum) for image-based food tracking and analysis, SNAQ is one of the most commonly used app in people with type 1 diabetes. Up to date, more than 40000 users have downloaded the SNAQ app in their phones, of which 2,500 are living in Switzerland.
The investigators have previously demonstrated that the system estimates the macronutrient content of real meals with satisfying accuracy.
However, evidence with regards to the effect of the food analysis on daily self-management of people with type 1 diabetes (e.g. glucose control, meal patterns, perceived benefits) is currently lacking. The investigators therefore aim to address these aspects in a randomized-controlled study contrasting the use of the SNAQ app with people's traditional meal management techniques.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The study will follow a randomized two-arm parallel design. Study visits will be done remotely via video calls or in-clinic when coinciding with usual care appointments. Following a baseline visit and before randomization, baseline characteristics and medical history of the participants will be collected (as detailed in section 4.3). Following randomization, the intervention group will use SNAQ app for the first 3 weeks while the control group will proceed without any modification/intervention by the study team. After the first 3 weeks, the control group will undergo 3 weeks of SNAQ app use (weeks 4-6). At the end of their respective SNAQ app periods (weeks 4-6 for the intervention group and weeks 7-9 for the control group), both groups will discontinue the use of SNAQ app for 3 weeks to assess sustainability of potential effects. Finally, both groups will be offered to use SNAQ app for 3 additional weeks as per their preference (follow-up period).
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Other: SNAQ appThe intervention group will use SNAQ app for the first 3 weeks (baseline to V1) of the study. |
| Control | Active comparator | Other: Traditional carbohydrate countingThe control group will continue estimating the carbohydrate count using their traditional methods for the first three weeks of the study (baseline to V1). |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Written informed consent
- Adults (aged 18 years or older)
- Type 1 diabetes (as defined by World Health Organization (WHO) for at least 12 month)
- Current use of a commercial hybrid closed-loop system
- HbA1c≤12% (measured within the past 3 months)
Key exclusion criteria (8 listed)
- Any physical or psychological disease or condition likely to interfere with the normal conduct of the study and interpretation of the study results
- Previous use of SNAQ app for more than 5 days within the past 3 months
- Self-reported pregnancy, planed pregnancy within next 3 months or breast-feeding
- Severe visual impairment
- Severe hearing impairment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SNAQ appSNAQ is a smartphone food analysis app that estimates the macronutrient content of a meal, based on a single image. The app first determines meal content in terms of food components with input from the user to correct or add further components (e.g. foods, ingredients, sauces, herbs or seasonings). Then, the total macronutrient and energy content of the meal is determined based on the estimated volume and information from a nutritional database. Of note, the application also allows for assessing nutritional content of packaged foods by means of a barcode scanning function. The user can always adapt proposed nutritional contents at their own discretion. Meal macronutrients alongside the food pictures are collected in a detailed log which allows users to review their dietary choices. The product is not conceived by its manufacturer to be used for medical purposes and can thus not be considered a medical device. | Other | Intervention |
| Traditional carbohydrate countingPatients will follow their traditional methods of carbohydrate counting during the control period. In addition to assess sustainability of the intervention, following the control period, the control group will also go an intervention period of 3 weeks using the SNAQ App. | Other | Control |
Primary outcome
Percentage of time with sensor glucose in the target range
Time frame: 3-week intervention period (Day 1 to Day 21)
Percentage of time with sensor glucose in the target range between 3.9 to 10.0mmol/L, %
11 secondary outcomes
Percentage of time with sensor glucose in hyperglycaemia
Time frame: 3-week intervention period (Day 1 to Day 21)
Percentage of time with sensor glucose in hypoglycaemia
Time frame: 3-week intervention period (Day 1 to Day 21)
Percentage of postprandial time with sensor glucose in target range
Time frame: 3-week intervention period (Day 1 to Day 21)
Percentage of postprandial time with sensor glucose in hyperglycaemia
Time frame: 3-week intervention period (Day 1 to Day 21)
Percentage of postprandial time with sensor glucose in hypoglycaemia
Time frame: 3-week intervention period (Day 1 to Day 21)
Sustainability: Change in percentage of time with sensor glucose in the target range
Time frame: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Sustainability: Change in the percentage of time with sensor glucose in hyperglycaemia
Time frame: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Sustainability: Change in the percentage of time with sensor glucose in hypoglycaemia
Time frame: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Sustainability: Change in the percentage of time with postprandial sensor glucose in target range
Time frame: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Sustainability: Change in the percentage of time with postprandial sensor glucose in hyperglycaemia
Time frame: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Sustainability: Change in the percentage of postprandial time with sensor glucose in hypoglycaemia
Time frame: 2-3-weeks before period with intervention compared with the 3 weeks after intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Jun 2026.
- Individual participant dataSharing planned: Yes. Anonymised individual participant data will be shared after inquiry via a validated sharing platform (yet to be defined). Anonymised data packages will be available once the final study results are published in a peer-reviewed journal.
Related trials for Type 1 Diabetes
Active, not recruitingPhase 3
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
Type 1 Diabetes
RecruitingObservational study
Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy
Type 1 Diabetes
Active, not recruitingPhase 1/2
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Obesity
RecruitingPhase 3
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Not yet recruitingPhase 1/2
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Sarcoma, Osteoid Sarcoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lia Bally, MD PhD principal investigator
UDEM Inselspital, University Hospital of Berne, and University Berne
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing SNAQ app and Traditional carbohydrate counting in people with Type 1 Diabetes, run by Lia Bally at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of time with sensor glucose in the target range (time frame: 3-week intervention period (Day 1 to Day 21)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2026.